Fox BIOSYSTEMS has developed the White FOx, a fiber‑optic SPR system that uses a microfluidics‑free dip‑in protocol for fast, user‑friendly sensing. The White FOx eliminates clogging and cross‑contamination with complex samples (lysates, whole blood, large particles) and supports interchangeable sensor probes with multiple surface chemistries. Its platform can detect antibodies, nanobodies, microvesicles, phages and large particles and enables kinetic affinity analysis, label‑free quantification and rapid ultra‑sensitive sandwich assays on unpurified samples. The company positions the product for broad use in life‑science and biopharmaceutical research labs. Fox BIOSYSTEMS says the new capital will be used to scale operations, accelerate development into new application areas and boost commercialisation. The company is based in Diepenbeek, Belgium, and describes a mission to revolutionize life‑science and pharmacological research with real‑time, label‑free analysis products. The announcement notes recent external support including an EIC grant alongside this financing.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2023